{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-001058","form_type":"8-K","ticker":"LFMD","cik":"0000948320","company_name":"LifeMD, Inc.","filed_at":"2022-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.502126+00:00","generated_at":"2026-06-27T18:48:53.383672+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"LifeMD acquires allergy telehealth platform Cleared; total consideration up to $76.7M","bullets":["Upfront $460k cash + $3.46M milestone payments + up to $72.8M earn-out based on $150M revenue.","Acquisition expected to close in Q1 2022; Cleared provides allergy/asthma telehealth in all 50 states.","Deal expected to be accretive to LifeMD's Adjusted EBITDA in 2022 and significantly accretive thereafter.","LifeMD also purchasing a $507k convertible note from a strategic pharma investor alongside the acquisition."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-001058","json":"https://secwatch.observer/filing/0001493152-22-001058.json","markdown":"https://secwatch.observer/filing/0001493152-22-001058.md","text":"https://secwatch.observer/filing/0001493152-22-001058.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/948320/000149315222001058/0001493152-22-001058-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/948320/000149315222001058/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T18:48:53.383672+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}